Global Systemic Antiviral Pharmaceuticals Market
Antiviral drugs are a class of medication that inhibits the
development of infection causing viruses. Like antibiotics, specific
antiviral drugs are used against specific viruses. As viruses share
most of the metabolic processes with the host cell, it is difficult
to commercialize new medications that are selective in action. The
presently available antiviral agents either act as DNA polymerase
inhibitors, reverse transcriptase inhibitors, protease inhibitors,
immunomodulators, neuraminidase inhibitors or integrase strand
transfer inhibitors.
Request Report Brochure @
https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=12287
Global Systemic Antiviral Pharmaceuticals Market: Segmentation
Antiviral drugs can be administered by various methods such as
topical or local application, systemic delivery, controlled delivery
and targeted delivery. Systemic drug delivery is relatively safe and
effective for the treatment than topical agents. In recent times,
systemic delivery method is gaining attention owing to its higher
therapeutic efficacy and bioavailability. The demand for products
with systemic application is high especially in the treatment for
chronic viral infections such as hepatitis and HIV infection.
Based on the class of antiviral drugs, the global systemic antiviral
pharmaceuticals market is segmented into DNA polymerase inhibitors,
reverse transcriptase inhibitors, protease inhibitors,
immunomodulators, interferon, neuraminidase inhibitors and integrase
strand transfer inhibitors. Increasing resistance to M2 inhibitors
has shifted the focus towards neuraminidase inhibitors for the
treatment of influenza. Neuraminidase inhibitors class of drugs
includes Oseltamivir and Zanamivir which are administered through
systemic route. Herpes virus can be treated using medications such as
Acyclovir, Brivudin, Cidofovir, Famciclovir, Fomivirsen, Foscarnet,
Ganciclovir, Penciclovir, Valacyclovir, Vidarabine and
Valganciclovir.
Based on the disease type, the global systemic antiviral
pharmaceuticals market can be analyzed as herpes, hepatitis,
influenza and HIV infection. Recent advancements in the field of
antiviral treatment for herpes infection have inclined the
ophthalmologists to treat severe ocular infection caused by herpes
virus. In addition, the acute retinal necrosis (ARN) syndrome caused
by herpes virus and retinal infection caused by cytomegalovirus is
also treated using systemic antiviral drugs. Vidarabine, Acyclovir,
Ganciclovir, and Foscarnet are the four major systemic antivral drugs
used in the treatment of ophthalmic infections. Rising incidence of
herpes virus infections, as well as the rising epidemic of HIV
infections has led to increase in ophthalmic infections which drive
the demand for systemic antiviral pharmaceuticals.
Enquiry for discount on this report @
https://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=12287
Global Systemic Antiviral Pharmaceuticals Market: Geographical
Dynamics
The demand for systemic antiviral pharmaceuticals is high in regions
with high prevalence of herpes, influenza, hepatitis and HIV
infection. According to World Health Organization (WHO), worldwide
35.3 million people were living with HIV infection at the end of
2012. The prevalence is high in the African region where nearly one
in 20 adults is living with HIV infection. Further, the prevalence of
herpes simplex virus type 2 is high in Africa, North America and some
parts of Asia-Pacific. Early and effective treatment is therefore the
primary need in these regions. Hence, the demand for systemic
antiviral pharmaceuticals will increase with growing incidence of
viral infections.
Some of the major players in the systemic antiviral pharmaceuticals
market are GlaxoSmithKline plc, Bristol-Myers Squibb, Gilead
Sciences, F. Hoffmann-La Roche Ltd., Pfizer, Inc., Boehringer
Ingelheim, Abbott Laboratories and Merck & Co., Inc.
Request for the TOC of the Report @ https://www.transparencymarketresearch.com/sample/sample.php?flag=T&rep_id=12287
About Us
Transparency Market Research is a next-generation market intelligence
provider, offering fact-based solutions to business leaders,
consultants, and strategy professionals.
Our reports are single-point solutions for businesses to grow,
evolve, and mature. Our real-time data collection methods along with
ability to track more than one million high growth niche products are
aligned with your aims. The detailed and proprietary statistical
models used by our analysts offer insights for making right decision
in the shortest span of time. For organizations that require specific
but comprehensive information we offer customized solutions through
adhoc reports. These requests are delivered with the perfect
combination of right sense of fact-oriented problem solving
methodologies and leveraging existing data repositories.
TMR believes that unison of solutions for clients-specific problems
with right methodology of research is the key to help enterprises
reach right decision.
US Office Contact
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email:
sales@transparencymarketresearch.com
Website:
https://www.transparencymarketresearch.com
No comments:
Post a Comment